Niigata, Japan

Suguru Takeuchi

This inventor holds 1 USPTO granted patent. Top assignee: Niigata University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Suguru Takeuchi. Retrieved from https://idiyas.com/inventor/suguru-takeuchi-chlpiw56

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Suguru Takeuchi: Innovator in Macrophage Induction

Introduction

Suguru Takeuchi is a prominent inventor based in Niigata, Japan. He has made significant contributions to the field of immunology, particularly in the induction of macrophages. His innovative work has led to advancements in anti-inflammatory treatments.

Latest Patents

Suguru Takeuchi holds 1 patent for an induction method for macrophages, an anti-inflammatory macrophage-inducing agent, and a pharmaceutical composition. This patent describes a method where macrophages are cultured in the presence of exosomes produced from mesenchymal stem cells that have been treated with interferon gamma. The resulting macrophages are induced into an anti-inflammatory state, which has potential therapeutic applications.

Career Highlights

Suguru Takeuchi is affiliated with Niigata University, where he conducts his research and development. His work focuses on enhancing the understanding of macrophage behavior and their role in inflammation. This research is crucial for developing new treatments for various inflammatory diseases.

Collaborations

Suguru Takeuchi collaborates with notable colleagues, including Shuji Terai and Atsunori Tsuchiya. Their combined expertise contributes to the advancement of research in macrophage biology and therapeutic applications.

Conclusion

Suguru Takeuchi's innovative work in macrophage induction represents a significant step forward in immunology. His contributions have the potential to lead to new anti-inflammatory therapies that could benefit many patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…